Results 151 to 160 of about 1,947,962 (285)
Clinical Ophthalmology, 2015 Noriko Kato,1,2 Genichiro Takahashi,1,2 Koichi Kumegawa,1,2 Yoshiaki Kabata,1,2 Hiroshi Tsuneoka1 1Department of Ophthalmology, Jikei University, School of Medicine, 2Katsushika Medical Center, Tokyo, Japan Background: We investigated indications and ...
Kato N +4 more
doaj
Multimedia-based Medicinal Plants Sustainability Management System [PDF]
IJCSI International Journal of Computer Science Issues, Vol. 8,
Issue 5, No 3, September 2011; ISSN (Online): 1694-0814, 2011 Medicinal plants are increasingly recognized worldwide as an alternative source of efficacious and inexpensive medications to synthetic chemo-therapeutic compound. Rapid declining wild stocks of medicinal plants accompanied by adulteration and species substitutions reduce their efficacy, quality and safety.
arxiv
Low‐Cost New Glaucoma Drainage Device in Indonesia: One Year Follow‐Up of 252 Subjects
Clinical &Experimental Ophthalmology, EarlyView.ABSTRACT Background To evaluate the early efficacy and safety of a new polymethyl methacrylate 200 mm2 non‐valved glaucoma drainage device (GDD) designed for Indonesian use over a 12 month period. Methods This was a prospective study following subjects with various forms of refractory glaucoma aged ≥ 7 years old followed for 12 months. The subjects had
Virna Dwi Oktariana Asrory +1 more
wiley +1 more source
mTORC1 regulates cytokinesis through activation of Rho-ROCK signaling [PDF]
arXiv, 2015 Understanding the mechanisms by which cells coordinate their size with their ability to divide has long attracted the interest of biologists. The Target of Rapamycin (TOR) pathway is becoming increasingly recognized as a master regulator of cell size, however less is known how TOR activity might be coupled with the cell cycle.
arxiv
Long‐Term Morphological Changes of Crosslinked Gelatin Stent
Clinical &Experimental Ophthalmology, EarlyView.ABSTRACT Background This study investigates the long‐term morphological outcomes of crosslinked gelatin stents over a 10‐year period. Methods Participants from the FDA phase 1 and 2 trials for the XEN 140 stent were recalled for follow‐up examinations between 9 and 12 years after their initial implantation.
Yuen Keat Gan +3 more
wiley +1 more source
Clinical characteristics and treatment outcomes of linear IgA bullous dermatosis
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.Summary Linear immunoglobulin A (IgA) bullous dermatosis (LABD), also referred to as chronic bullous disease of childhood (CBDC), is characterized by the linear deposition of IgA antibodies within the dermal‐epidermal junction. While dapsone is typically recommended, alternative modalities may be considered based on accessibility, severity, and prior ...
Kristie Mar +7 more
wiley +1 more source
Epilepsia, EarlyView.Abstract Objective Degeneration of hilar mossy cells in the dentate gyrus is an important hallmark of hippocampal sclerosis and is often observed in patients with temporal lobe epilepsy. To understand the pathogenesis of hippocampal sclerosis and develop novel neuroprotective treatments, it is critical to determine the mechanistic processes of mossy ...
Carolin Christina Koretz +5 more
wiley +1 more source
Equine Veterinary Journal, EarlyView.Abstract Background Temporohyoid osteoarthropathy (THO) is characterised by bone proliferation and cartilage ossification caused by infectious and degenerative conditions, amongst others. Objectives To describe the variable appearance of the temporohyoid joint (THJ) on computed tomography (CT) and investigate associations between CT changes and ...
Rupert F. Dash +3 more
wiley +1 more source
Endometrial adenosarcoma in the setting of a germline DICER1 mutation: A case report [PDF]
, 2017 Babb, Sheri +4 more
core +3 more sources